Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Injectable Asthma Medications prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Influenza Drugs Tamiflu and Relenza prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Immunomodulators for Skin Conditions prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Immunoglobulins Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Immune Modulating Drugs prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Hypoactive Sexual Desire Disorder (HSDD) Policy prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Home Total Parenteral Nutrition TPN prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Home Infusion Therapy Prior Authorization Form prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | HETLIOZ tasimelteon prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Heart Failure and Hypertrophic Cardiomyopathy (HCM) Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Growth Hormone and Insulin-like Growth Factor prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Related Drugs for the Treatment of Type 2 Diabetes | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | GLP-1 and GLP-1 - GIP Agonist Drugs for Anti-Obesity Management and Other Non-Obesity Conditions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapy for Dystrophic Epidermolysis Bullosa - Zevaskyn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapy for Cerebral Adrenoleukodystrophy SKYSONA | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapies for Metaloleukodystrophy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapies for Hemophilia A or B | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapies for Duchenne Muscular Dystrophy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Gene Therapies for Aromatic L-amino Acid Decarboxylase Deficiency | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Fentanyl, oral-transmucosal prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Factor and Non-Factor Anti-Hemophilic Drugs | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Esketamine Nasal Spray (SpravatoTM) and Intravenous Ketamine for Mental Health Conditions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Erythropoietin, Recombinant Human and Hypoxia-Inducible Factor Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Entyvio (Vedolizumab) Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Engineered T-Cell Therapy Synovial Sarcoma Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Elzonris (tagraxofusp-erzs) for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | E Form medication prior auth instruction prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Drugs for the Treatment of Hereditary Angioedema HAE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Drugs for Macular Degeneration and Diabetic Eye Disease | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Drugs for Cystic Fibrosis prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Drug Management and Prior Authorization prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Drug Management & Retail Pharmacy Prior Authorization and Step Therapy Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Diabetes Step Therapy prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Compounded Medications prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Compound Medications Inclusion Drug List prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Compound Medications Exclusion Drug List prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | CNS Stimulants and Psychotherapeutic Agents prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Cell and Gene Therapy for Ocular Diseases | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Carelon Oncology Medication Management Program | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Botulinum Toxin Injections SP prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | 621B Quality Care Dosing Guidelines Drug List prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Asthma and Chronic Obstructive Pulmonary Disease Medication Management prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Antisense Oligonucleotide Medications prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Antihyperlipidemics prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Anti-Parkinsonism Drugs prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Anti-Migraine Policy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Adoptive Cell Therapies for Melanoma | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | 621A Quality Care Dosing Guidelines prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Wearable Cardioverter Defibrillators prn | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Massachusetts | Urological Supplies | New policy |